SEC Form D · filed February 18, 2022
Gilgamesh Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Amy Kruse · New York, NYDirectorAndrew Kruegel · New York, NYExec · DirectorRobert Berman · New York, NYDirectorJonathan Sporn · New York, NYExec · DirectorPhil Skolnick · New York, NYDirectorMichael S. Downing · West Des Moines, IADirectorJulie B. Sanders · Dallas, TXExec · DirectorJohn P. Golden · El Segundo, CADirectorShawn O'Brien · NOVI, MIDirectorEdward Harycki · Bryn Mawr, PAExec · DirectorJames T. Farrell · San Francisco, CAExec · DirectorGaurav Sahni · Short Hills, X1Exec · DirectorChris Wood · Seattle, WADirectorAutum Grimm · Seattle, WADirectorSimon Barnes · Grand Duchy of Luxembourg, LuxembourgDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗